ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops and manufactures novel recombinant enzymes from Arctic marine organisms.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 128.9 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 129.7 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 126.4 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 129.4 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 130.1 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program…
Norwegian 129.0 KB
2025-12-04 07:30
ArcticZymes Technologies Sell Shares to Support Employee Share Purchase Program
English 2.8 KB
2025-11-28 17:03
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 67.0 KB
2025-11-28 17:03
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 98.6 KB
2025-11-28 17:03
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 2.4 KB
2025-11-10 22:00
Long-Term Incentive Plan - grant of share options to primary insiders - Attachm…
English 1.5 MB
2025-11-10 22:00
Long-Term Incentive Plan - grant of share options to primary insiders
English 2.3 KB
2025-11-06 07:00
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 272.3 KB
2025-11-06 07:00
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 1.7 MB
2025-11-06 07:00
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 2.9 MB

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArcticZymes Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.